What is brimonidine used for?

Indications and Usage, quoted from the label by Upsher-Smith Laboratories, LLC (ANDA216772). Cross-references to other label sections are left out.

Brimonidine tartrate ophthalmic solution 0.15% is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.

Source: DailyMed label, set id ee46049d-9f9b-4fb6-b47a-2631971f711c, version 2, effective November 1, 2025. NDC 0832-1420, one of 24 listings for this product.

Indications and Usage, quoted from the label by Padagis Israel Pharmaceuticals Ltd (ANDA209158). Cross-references to other label sections are left out.

Brimonidine topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) erythema of rosacea in adults 18 years of age or older.

Source: DailyMed label, set id c899b329-cc5e-4443-8e94-451314de47c9, version 4, effective July 31, 2024. NDC 45802-078, one of 2 listings for this product.

Indications and Usage, quoted from the label by Sandoz Inc (ANDA076254). Cross-references to other label sections are left out.

Brimonidine tartrate ophthalmic solution, 0.2% is indicated for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

The IOP lowering efficacy of brimonidine tartrate ophthalmic solution diminishes over time in some patients. This loss of effect appears with a variable time of onset in each patient and should be closely monitored.

Source: DailyMed label, set id dfd85672-fa4b-40e3-ac9c-81b8d9e4ffde, version 7, effective May 30, 2025. NDC 61314-143, one of 1 listing for this product.